PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound - WSJ

Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound  WSJ

23 Feb, 16:44 — 23 Feb, 16:44
PostShare

Sources

Showing 1 of 1 sources
wsjHigh48d ago

Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound - WSJ

Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound  WSJ

Read full article →

Related Stories

Study Suggests Syphilis-Like Disease Spread in Ancient Vietnam, Challenging Columbus Theory

just now

Understanding and Managing Postpartum Sweating

20m ago

Protecting Dogs from Viper Bites as Weather Warms

33m ago

Protecting Dogs from Viper Bites as Warmer Weather Arrives

33m ago